A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.

Abstract:

BACKGROUND:We previously identified TrkB as an oncogene involved in promoting metastasis in endometrial carcinoma (EC). Here, we sought to delineate the effect of changes in TrkB expression on the global profile of microRNAs (miRNAs) in EC cells and further investigated the correlation between the expression of certain miRNA and TrkB in the clinicopathologic characteristics of EC patients. METHODS AND RESULTS:Using quantitative reverse transcription-PCR (qRT-PCR), we found that expression of TrkB mRNA has no significant difference in transcript levels between normal endometrium and EC cells captured by laser capture microdissection, while immunohistochemistry results demonstrated a markedly higher expression of TrkB protein in EC tissues. The microRNA array showed that ectopic overexpression and knockdown of TrkB expression caused global changes in miRNA expression in EC cells. qRT-PCR results showed that elevated TrkB repressed miR-204-5p expression in EC cells. Furthermore, immunoblotting assays revealed that TrkB overexpression in IshikawaTrkB cells noticeably increased JAK2 and STAT3 phosphorylation, which, however, was aborted by TrkB knockdown in HEC-1BshTrkB cells. Moreover, ChIP assays showed that phospho-STAT3 could directly bind to STAT3-binding sites near the TRPM3 promoter region upstream of miR-204-5p. Interestingly, using bioinformatics analysis and luciferase assays, we identified TrkB was a novel target of miR-204-5p. Functionally, the MTT assays, clonogenic and Transwell assays showed that miR-204-5p significantly suppressed the clonogenic growth, migration and invasion of EC cells. Furthermore, miR-204-5p also inhibited the growth of tumor xenografts bearing human EC cells. Importantly, we found lower miR-204-5p expression was associated with advanced FIGO stages, lymph node metastasis and probably a lower chance for survival in EC patients. CONCLUSIONS:This study uncovers a new regulatory loop involving TrkB/miR-204-5p that is critical to the tumorigenesis of EC and proposes that reestablishment of miR-204-5p expression could be explored as a potential new therapeutic target for this disease.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Bao W,Wang HH,Tian FJ,He XY,Qiu MT,Wang JY,Zhang HJ,Wang LH,Wan XP

doi

10.1186/1476-4598-12-155

subject

Has Abstract

pub_date

2013-12-09 00:00:00

pages

155

issn

1476-4598

pii

1476-4598-12-155

journal_volume

12

pub_type

杂志文章
  • Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

    abstract:BACKGROUND:MicroRNA-10b (miR-10b) has a prominent role in regulating tumor invasion and metastasis by targeting the HOXD10 transcriptional repressor and has been found up-regulated in several tumor types. METHODS:We evaluated the expression of miR-10b in paired tumor and normal specimens obtained from a prospective co...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-142

    authors: Parrella P,Barbano R,Pasculli B,Fontana A,Copetti M,Valori VM,Poeta ML,Perrone G,Righi D,Castelvetere M,Coco M,Balsamo T,Morritti M,Pellegrini F,Onetti-Muda A,Maiello E,Murgo R,Fazio VM

    更新日期:2014-06-04 00:00:00

  • HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.

    abstract:BACKGROUND:In previously published studies, oncolytic adenovirus-mediated gene therapy has produced good results in targeting cancer cells. However, safety and efficacy, the two most important aspects in cancer therapy, remain serious challenges. The specific expression or deletion of replication related genes in an ad...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-10-133

    authors: Xu HN,Huang WD,Cai Y,Ding M,Gu JF,Wei N,Sun LY,Cao X,Li HG,Zhang KJ,Liu XR,Liu XY

    更新日期:2011-11-01 00:00:00

  • Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces.

    abstract:BACKGROUND:Aurora-A is an oncogenic kinase playing well-documented roles in mitotic spindle organisation. We previously found that Aurora-A inactivation yields the formation of spindles with fragmented poles that can drive chromosome mis-segregation. Here we have addressed the mechanism through which Aurora-A activity ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-10-131

    authors: Asteriti IA,Giubettini M,Lavia P,Guarguaglini G

    更新日期:2011-10-19 00:00:00

  • mRNA-to-protein translation in hypoxia.

    abstract::Cells respond to hypoxia by shifting cellular processes from general housekeeping functions to activating specialized hypoxia-response pathways. Oxygen plays an important role in generating ATP to maintain a productive rate of protein synthesis in normoxia. In hypoxia, the rate of the canonical protein synthesis pathw...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12943-019-0968-4

    authors: Chee NT,Lohse I,Brothers SP

    更新日期:2019-03-30 00:00:00

  • DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.

    abstract:BACKGROUND:The exposure of skin keratinocytes to Ultraviolet (UV) irradiation leads to Akt phosphorylation at Ser-473, which is important for the carcinogenic effects of excessive sun exposure. The present study investigated the underlying mechanism of Akt Ser-473 phosphorylation by UVB radiation. RESULTS:We found tha...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-12-172

    authors: Tu Y,Ji C,Yang B,Yang Z,Gu H,Lu CC,Wang R,Su ZL,Chen B,Sun WL,Xia JP,Bi ZG,He L

    更新日期:2013-12-24 00:00:00

  • MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.

    abstract:BACKGROUND:Perturbation of DNA methylation is frequent in cancers and has emerged as an important mechanism involved in tumorigenesis. To determine how DNA methylation is modified in the genome of primary glioma, we used Methyl-DNA immunoprecipitation (MeDIP) and Nimblegen CpG promoter microarrays to identify different...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-10-124

    authors: Zhang Z,Tang H,Wang Z,Zhang B,Liu W,Lu H,Xiao L,Liu X,Wang R,Li X,Wu M,Li G

    更新日期:2011-09-30 00:00:00

  • PTEN inhibits BMI1 function independently of its phosphatase activity.

    abstract:BACKGROUND:PTEN is the second most mutated tumor suppressor gene other than p53. It suppresses tumorigenesis by dephosphorylating phosphatidylinositol (3,4,5)-triphosphate (PIP3) to phosphatidylinositol (4,5)-biphosphate (PIP2), thereby directly inhibiting phosphatidylinositol 3 kinase (PI3K)-mediated tumorigenic activ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-8-98

    authors: Fan C,He L,Kapoor A,Rybak AP,De Melo J,Cutz JC,Tang D

    更新日期:2009-11-10 00:00:00

  • Epigenetic aberrations and cancer.

    abstract::The correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer. ...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/1476-4598-5-60

    authors: Ducasse M,Brown MA

    更新日期:2006-11-08 00:00:00

  • Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

    abstract:BACKGROUND:Transforming Growth Factor beta (TGF-beta) plays an important role in tumor invasion and metastasis. We set out to investigate the possible clinical utility of TGF-beta antagonists in a human metastatic basal-like breast cancer model. We examined the effects of two types of the TGF-beta pathway antagonists (...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-122

    authors: Ganapathy V,Ge R,Grazioli A,Xie W,Banach-Petrosky W,Kang Y,Lonning S,McPherson J,Yingling JM,Biswas S,Mundy GR,Reiss M

    更新日期:2010-05-26 00:00:00

  • Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.

    abstract:BACKGROUND:The influence of natural regulatory T cells (nTregs) on the patients with colon cancer is unclear. Demethylated status of the Treg-specific demethylated region (TSDR) of the FOXP3 gene was reported to be a potential biomarker for the identification of nTregs. METHODS:The demethylation rate of the TSDR (TSDR...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-153

    authors: Zhuo C,Li Z,Xu Y,Wang Y,Li Q,Peng J,Zheng H,Wu P,Li B,Cai S

    更新日期:2014-06-18 00:00:00

  • Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.

    abstract:BACKGROUND:New therapies are urgently needed for patients with small cell lung cancer (SCLC). Chemotherapy and targeted therapies, including the Bcl-2 inhibitor ABT-737, may induce tumor cell autophagy. Autophagy can promote survival of cancer cells under stress and comprise a pathway of escape from cytotoxic therapies...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-12-16

    authors: Zinn RL,Gardner EE,Dobromilskaya I,Murphy S,Marchionni L,Hann CL,Rudin CM

    更新日期:2013-03-02 00:00:00

  • Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

    abstract:BACKGROUND:The human cell cycle transcription factor FOXM1 is known to play a key role in regulating timely mitotic progression and accurate chromosomal segregation during cell division. Deregulation of FOXM1 has been linked to a majority of human cancers. We previously showed that FOXM1 was upregulated in basal cell c...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-45

    authors: Teh MT,Gemenetzidis E,Chaplin T,Young BD,Philpott MP

    更新日期:2010-02-26 00:00:00

  • The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells.

    abstract::Bortezomib is a novel anti-cancer agent which has shown promising activity in non-small lung cancer (NSCLC) patients. However, only a subset of patients respond to this treatment. We show that NSCLC cell lines are differentially sensitive to bortezomib, IC50 values ranging from 5 to 83 nM. The apoptosis-inducing poten...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-6-73

    authors: Voortman J,Checińska A,Giaccone G

    更新日期:2007-11-17 00:00:00

  • Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1.

    abstract:BACKGROUND:New blood vessel formation, or angiogenic switch, is an essential event in the development of solid tumors and their metastatic growth. Tumor blood vessel formation and remodeling is a complex and multi-step processes. The differentiation and recruitment of mural cells including vascular smooth muscle cells ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-209

    authors: Dhar K,Dhar G,Majumder M,Haque I,Mehta S,Van Veldhuizen PJ,Banerjee SK,Banerjee S

    更新日期:2010-08-05 00:00:00

  • Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27.

    abstract:BACKGROUND:Hypoxia can halt cell cycle progression of several cell types at the G1/S interface. The arrest needs to be overcome by cancer cells. We have previously shown that the hypoxia-inducible cellular oxygen sensor PHD3/EGLN3 enhances hypoxic cell cycle entry at the G1/S boundary. METHODS:We used PHD3 knockdown b...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-015-0410-5

    authors: Högel H,Miikkulainen P,Bino L,Jaakkola PM

    更新日期:2015-07-30 00:00:00

  • A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12.

    abstract::Monoclonal antibodies represent some of the most promising molecular targeted immunotherapies. However, understanding mechanisms by which tumors evade elimination by the immune system of the host presents a significant challenge for developing effective cancer immunotherapies. The interaction of cancer cells with the ...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/1476-4598-9-242

    authors: Klinke DJ 2nd

    更新日期:2010-09-15 00:00:00

  • Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo.

    abstract::The mammalian target of rapamycin (mTOR), which exists in two functionally distinct complexes, mTORC1 and mTORC2 plays an important role in tumor growth. Whereas the role of mTORC1 has been well characterized in this process, little is known about the functions of mTORC2 in cancer progression. In this study, we explor...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-57

    authors: Roulin D,Cerantola Y,Dormond-Meuwly A,Demartines N,Dormond O

    更新日期:2010-03-12 00:00:00

  • Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.

    abstract:BACKGROUND:Triple negative breast cancer (TNBC) remains the most challenging breast cancer subtype so far. Specific therapeutic approaches have rarely achieved clinical improvements in treatment of TNBC patients and effective molecular biomarkers are largely unknown. METHODS:We used paired TNBC samples and high throug...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-020-01259-6

    authors: Li J,Ma M,Yang X,Zhang M,Luo J,Zhou H,Huang N,Xiao F,Lai B,Lv W,Zhang N

    更新日期:2020-09-11 00:00:00

  • miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.

    abstract:BACKGROUND:microRNAs (miRNAs) play both oncogenic and oncostatic roles in leukemia. However, the molecular details underlying miRNA-mediated regulation of their target genes in pediatric B- and T-cell acute lymphoblastic leukemias (ALLs) remain unclear. The present study investigated the relationship between miR-2909 a...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-175

    authors: Malik D,Kaul D,Chauhan N,Marwaha RK

    更新日期:2014-07-18 00:00:00

  • Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.

    abstract:BACKGROUND:Gastrointestinal stromal tumour (GIST) is the most common soft tissue sarcoma. The identification of the molecular mechanisms regulating GIST progression is vital for its treatment and prevention. Increasing reports have demonstrated that epigenetic alterations play critical roles in GIST development. Howeve...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-018-0861-6

    authors: Hu F,Li H,Liu L,Xu F,Lai S,Luo X,Hu J,Yang X

    更新日期:2018-07-30 00:00:00

  • ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.

    abstract:BACKGROUND:Aspartate β-hydroxylase (ASPH) is silent in normal adult tissues only to re-emerge during oncogenesis where its function is required for generation and maintenance of malignant phenotypes. Exosomes enable prooncogenic secretome delivering and trafficking for long-distance cell-to-cell communication. This stu...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-019-1077-0

    authors: Lin Q,Chen X,Meng F,Ogawa K,Li M,Song R,Zhang S,Zhang Z,Kong X,Xu Q,He F,Bai X,Sun B,Hung MC,Liu L,Wands J,Dong X

    更新日期:2019-11-07 00:00:00

  • Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.

    abstract:BACKGROUND:An increasing number of studies support the presence of stem-like cells in human malignancies. These cells are primarily responsible for tumor initiation and thus considered as a potential target to eradicate tumors. CD133 has been identified as an important cell surface marker to enrich the stem-like popula...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-39

    authors: Tabu K,Kimura T,Sasai K,Wang L,Bizen N,Nishihara H,Taga T,Tanaka S

    更新日期:2010-02-19 00:00:00

  • Glycerol as a chemical chaperone enhances radiation-induced apoptosis in anaplastic thyroid carcinoma cells.

    abstract:INTRODUCTION:Anaplastic thyroid carcinoma, which is one of the most aggressive, malignant tumors in humans, results in an extremely poor prognosis despite chemotherapy and radiotherapy. The present study was designed to evaluate therapeutic effects of radiation by glycerol on p53-mutant anaplastic thyroid carcinoma cel...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-1-4

    authors: Ohnishi K,Ota I,Yane K,Takahashi A,Yuki K,Emoto M,Hosoi H,Ohnishi T

    更新日期:2002-10-04 00:00:00

  • Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells.

    abstract:BACKGROUND:Hedgehog acyltransferase (Hhat) catalyzes the transfer of the fatty acid palmitate onto Sonic Hedgehog (Shh), a modification that is essential for Shh signaling activity. The Shh signaling pathway has been implicated in the progression of breast cancer. METHODS:To determine the functional significance of Hh...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-015-0345-x

    authors: Matevossian A,Resh MD

    更新日期:2015-04-01 00:00:00

  • IRF5 promotes the proliferation of human thyroid cancer cells.

    abstract:BACKGROUND:Interferon Regulatory Factor 5 is a transcription factor that regulates the expression of genes involved in the response to viral infection and in the stimulation of the immune system. Moreover, multiple studies have demonstrated that it negatively regulates cell growth and oncogenesis, favoring cell differe...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-11-21

    authors: Massimino M,Vigneri P,Fallica M,Fidilio A,Aloisi A,Frasca F,Manzella L

    更新日期:2012-04-16 00:00:00

  • Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.

    abstract:BACKGROUND:Reactive oxygen species contribute to normal thyroid function. The NRF2 oxidative response pathway is frequently and constitutively activated in multiple tumor types, including papillary thyroid carcinoma (PTC). Genetic mechanisms underlying NRF2 pathway activation in PTC are not fully understood. Thus, we a...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-12-124

    authors: Martinez VD,Vucic EA,Pikor LA,Thu KL,Hubaux R,Lam WL

    更新日期:2013-10-20 00:00:00

  • The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.

    abstract:BACKGROUND:Human clear cell renal cell carcinoma (CRCC) remains resistant to therapies. Recent advances in Hypoxia Inducible Factors (HIF) molecular network led to targeted therapies, but unfortunately with only limited clinical significance. Elucidating the molecular processes involved in kidney tumorigenesis and resi...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-8-123

    authors: Dormoy V,Danilin S,Lindner V,Thomas L,Rothhut S,Coquard C,Helwig JJ,Jacqmin D,Lang H,Massfelder T

    更新日期:2009-12-16 00:00:00

  • Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

    abstract:BACKGROUND:Inactivation of the Fanconi anemia (FA) pathway through defects in one of 13 FA genes occurs at low frequency in various solid cancer entities among the general population. As FA pathway inactivation confers a distinct hypersensitivity towards DNA interstrand-crosslinking (ICL)-agents, FA defects represent r...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-127

    authors: Palagyi A,Neveling K,Plinninger U,Ziesch A,Targosz BS,Denk GU,Ochs S,Rizzani A,Meier D,Thasler WE,Hanenberg H,De Toni EN,Bassermann F,Schäfer C,Göke B,Schindler D,Gallmeier E

    更新日期:2010-05-28 00:00:00

  • The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is one of the major causes of mortality. ABT-263 is a newly synthesized, orally available Bcl-2/xL inhibitor that shows promising efficacy in HCC therapy. ABT-263 inhibits the anti-apoptotic activity of Bcl-2 and Bcl-xL, but not Mcl-1. Previous reports have shown that ABT-263 u...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-98

    authors: Wang B,Ni Z,Dai X,Qin L,Li X,Xu L,Lian J,He F

    更新日期:2014-04-30 00:00:00

  • Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.

    abstract:BACKGROUND:The clinical use of BRAF inhibitors for treatment of metastatic melanoma is limited by the development of drug resistance. In this study we investigated whether co-targeting the MAPK and the PI3K-AKT pathway can prevent emergence of resistance or provide additional growth inhibitory effects in vitro. METHOD...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-83

    authors: Lassen A,Atefi M,Robert L,Wong DJ,Cerniglia M,Comin-Anduix B,Ribas A

    更新日期:2014-04-16 00:00:00